Table 4.
Replication mediation analyses of peak values* of biomarkers in MGH cohort.
| Total effect model† outcome: death | Mediator model† outcome: biomarker | Outcome model† outcome: death | Proportion mediated | ||
|---|---|---|---|---|---|
| OR (sex) | Estimate (sex) | OR (sex) | OR (biomarker) | ||
| hs-CRP | |||||
| All (n = 1,088) | 2.24 (p <0.001) | 0.102 (p = 0.058) | 2.09 (p = 0.002) | -‡ | 0.20 (p = 0.048) |
| Obese (n = 491) | 1.92 (p = 0.051) | 0.080 (p = 0.277) | 1.78 (p = 0.123) | 9.07 (p <0.001) | 0.22 (p = 0.284) |
| Non-obese (n = 597) | 2.44 (p = 0.002) | 0.144 (p = 0.065) | 2.18 (p = 0.012) | 4.64 (p <0.001) | 0.22 (p = 0.062) |
| Ferritin | |||||
| All (n = 1,070) | 2.33 (p <0.001) | 0.474 (p <0.001) | 2.04 (p = 0.002) | -‡ | 0.33 (p <0.001) |
| Obese (n = 483) | 1.96 (p = 0.046) | 0.510 (p <0.001) | 1.57 (p = 0.204) | 2.62 (p <0.001) | 0.51 (p = 0.010) |
| Non-obese (n = 587) | 2.64 (p = 0.001) | 0.456 (p <0.001) | 2.47 (p = 0.003) | 1.92 (p <0.001) | 0.24 (p <0.001) |
| D-dimer | |||||
| All (n = 1,050) | 2.17 (p <0.001) | 0.022 (p = 0.676) | 2.27 (p <0.001) | -‡ | 0.02 (p = 0.700) |
| ≥ 65 yrs (n = 421) | 2.00 (p = 0.005) | 0.025 (p = 0.762) | 2.13 (p = 0.003) | 1.99 (p <0.001) | 0.02 (p = 0.732) |
| <65 yrs (n = 629) | 3.21 (p = 0.041) | 0.025 (p = 0.718) | 3.29 (p = 0.044) | 2.97 (p <0.001) | 0.02 (p=0.710) |
| Creatinine | |||||
| All (n = 1,084) | 2.25 (p <0.001) | 0.568 (p <0.001) | 1.47 (p = 0.104) | 2.44 (p <0.001) | 0.57 (p <0.001) |
| hs-Troponin T | |||||
| All (n = 1,026) | 2.25 (p <0.001) | 0.194 (p <0.001) | 1.99 (p = 0.003) | 2.26 (p <0.001) | 0.19 (p = 0.002) |
Peak biomarker level was determined based on all measurements.
All values were natural log transformed and standardized for analysis;
All models included terms for sex and were adjusted for age, obesity, race/ethnicity, and the number of biomarker measurements.
The outcome model included both sex and the biomarker as predictor variables;
The outcome model included a biomarker by obesity interaction and therefore the main effect of the biomarker was not reported here.
OR, odds ratio; hs-CRP, high sensitivity C-reactive protein; hs-Troponin T, high sensitivity cardiac Troponin T.